Rethinking early cancer detection
EARLY DETECTION CHANCES OUTCOMES
Detecting cancer at earlier stages is often associated with improved outcomes, yet many cancers are still diagnosed too late.
LATE-STAGE DIAGNOSIS REMAINS ONE OF THE BIGGEST CHALLENGES IN CANCER
Most cancers develop silently and are only detected once symptoms appear - often when treatment options and outcomes become more limited.
Survival rates decline in advanced stages
Treatment becomes more complex and intensive
Costs rise significantly for patients and healthcare systems
THE IMPACT EXTENDS BEYOND DIAGNOSIS
For patients, it often means fewer treatment options and more aggressive therapies.
For healthcare systems, it leads to significantly higher costs due to complex and prolonged care.
The future of cancer care depends on earlier insight
A SHIFT TOWARDS EARLIER, SMARTER DETECTION
Advances in blood-based testing are making it increasingly possible to detect cancer before symptoms appear – opening the door to more proactive approaches to care.
At Wholomics, we are developing a next-generation multi-cancer early detection (MCED) test designed to advance the shift toward even earlier, more scalable blood-based cancer detection.
